370-05-040 ISMRM Abstract

The value of non-contrast cardiac magnetic resonance T1ρ mapping in assessing myocardial fibrosis in HCM and DCM

Primary: Cardiovascular - Myocardium

Secondary: Brain Function and fMRI

370-05-040 · Cardiac Metabolism and Diffusion · Monday, 11 May, 1:50 PM–2:45 PM · Traditional Posters | Exhibition Hall

Keywords: Magnetic resonance imaging HCM T1rho mapping Myocardial fibrosis DCM

Accepted

Jingjing Xu¹, Nan Zhang², Fan Du², Xiuzheng Yue ³, Hongfei Lu², Yiying Hua², Mengsu Zeng², Hang Jin^2,4,5

¹Department of Radiology, Zhongshan Hospital, Shanghai, China

²Zhongshan Hospital, Shanghai, China

³Clinical and Technical Support, Philips Healthcare (Beijing), Beijing, China

⁴Department of Radiology, Zhongshan Hospital, Fudan University, Shanghai, China

⁵Department of Medical Imaging, Shanghai Medical School, Fudan University, Shanghai, China

Presenting Author: Xiuzheng Yue

Synopsis

Motivation:

Goals:

Approach:

Results:

Full abstract & presentation

The full text, figures, and any recorded presentation for this abstract are not shown here. Log in if you are a member or registered attendee with access.

Full abstracts, figures, and presentations for Cape Town - 2026 ISMRM-ISMRT Annual Meeting and Exhibition are available to registered attendees. This content becomes freely available to the public roughly two years after the meeting.

To request or purchase access, contact the ISMRM Central Office at info@ismrm.org.

References

1. EICHHORN C, KOECKERLING D, REDDY R K, et al. Risk Stratification in Nonischemic Dilated Cardiomyopathy Using CMR Imaging: A Systematic Review and Meta-Analysis [J]. Jama, 2024, 332(18): 1535-50.·DOI:10.1001/jama.2024.13946https://dx.doi.org/10.1001/jama.2024.13946 [doi]

2. ZHAO K, ZHU Y, CHEN X, et al. Machine Learning in Hypertrophic Cardiomyopathy: Nonlinear Model From Clinical and CMR Features Predicting Cardiovascular Events [J]. JACC Cardiovasc Imaging, 2024, 17(8): 880-93.·DOI:10.1016/j.jcmg.2024.04.013https://dx.doi.org/10.1016/j.jcmg.2024.04.013 [doi]

3. LEINER T, BOGAERT J, FRIEDRICH M G, et al. SCMR Position Paper (2020) on clinical indications for cardiovascular magnetic resonance [J]. Journal of Cardiovascular Magnetic Resonance, 2020, 22(1): 76.·DOI:10.1186/s12968-020-00682-4https://dx.doi.org/10.1186/s12968-020-00682-4 [doi]

4. RAJIAH P S, FRANçOIS C J, LEINER T. Cardiac MRI: State of the Art [J]. Radiology, 2023, 307(3): e223008.·DOI:10.1148/radiol.223008https://dx.doi.org/10.1148/radiol.223008 [doi]

5. SALVADOR D B, JR., GAMBA M R, GONZALEZ-JARAMILLO N, et al. Diabetes and Myocardial Fibrosis: A Systematic Review and Meta-Analysis [J]. JACC Cardiovasc Imaging, 2022, 15(5): 796-808.·DOI：10.1016/j.jcmg.2021.12.008https://dx.doi.org/10.1016/j.jcmg.2021.12.008 [doi]

6. BUSTIN A, WITSCHEY W R T, VAN HEESWIJK R B, et al. Magnetic resonance myocardial T1ρ mapping : Technical overview, challenges, emerging developments, and clinical applications [J]. J Cardiovasc Magn Reson, 2023, 25(1): 34.·DOI:10.1186/s12968-023-00940-1https://dx.doi.org/10.1186/s12968-023-00940-1 [doi]

7. BUSTIN A, PINEAU X, SRIDI S, et al. Assessment of myocardial injuries in ischaemic and non-ischaemic cardiomyopathies using magnetic resonance T1-rho mapping [J]. European Heart Journal - Cardiovascular Imaging, 2023, 25(4): 548-57.·DOI:10.1093/ehjci/jead319https://dx.doi.org/10.1093/ehjci/jead319 [doi]

8. DONG Z, YIN G, YANG K, et al. Endogenous assessment of late gadolinium enhancement grey zone in patients with non-ischaemic cardiomyopathy with T1ρ and native T1 mapping [J]. Eur Heart J Cardiovasc Imaging, 2023, 24(4): 492-502.·DOI:10.1093/ehjci/jeac128https://dx.doi.org/10.1093/ehjci/jeac128 [doi]

9. WANG L, YUAN J, ZHANG S J, et al. Myocardial T1 rho mapping of patients with end-stage renal disease and its comparison with T1 mapping and T2 mapping: A feasibility and reproducibility study [J]. J Magn Reson Imaging, 2016, 44(3): 723-31.·DOI:10.1002/jmri.25188https://dx.doi.org/10.1002/jmri.25188 [doi]

Cite this abstract

http://echo.ismrm.org/p/ISMRM2026/370-05-040